NCT04275024 Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients Status COMPLETED Phase NA
NCT04274595 Role of Reverse Transcriptase Inhibitors in the Treatment of Psoriasis Status COMPLETED Phase NA
NCT04271735 Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis Status COMPLETED Phase NA
NCT04239521 The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata Status COMPLETED Phase N/A
NCT04200690 Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory Diseases Status UNKNOWN Phase NA
NCT04191395 Evolution and Treatments of Chronic Inflammatory Systemic Diseases Status RECRUITING Phase N/A
NCT04190758 GOTHA - The Early Arthritis and Psoriasis Study of Region Västra Götaland, Sweden Status ENROLLING_BY_INVITATION Phase N/A
NCT04175613 A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT04168619 MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic Tool Status UNKNOWN Phase N/A
NCT04167462 An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea Status COMPLETED Phase PHASE3
NCT04152382 A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis Status TERMINATED Phase PHASE1
NCT04149587 A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen Status COMPLETED Phase N/A